Delhi HC Quashes Patent Rejection in Fresenius Kabi Case
The Delhi High Court set aside the Controller’s refusal of Fresenius Kabi’s Sugammadex patent, citing procedural flaws under Section 14 of the Patents Act. The order underscores strict compliance with hearing requirements and warns against hindsight bias in inventive step analysis.